PE anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
a-30-F11_PE_090507
C57BL/6 mouse splenocytes stained with 30-F11 PE
  • a-30-F11_PE_090507
    C57BL/6 mouse splenocytes stained with 30-F11 PE
  • b-30-F11_PE_CD45_Antibody_2_041922
    C57BL/6 mouse splenocytes were stained with CD45 (clone 30-F11) PE (solid line) or rat IgG2b, κ PE isotype control (dashed line).

    Data was acquired on the Moxi Flow, exported, and processed using FlowJo software.
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
103105 50 µg £31
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103106 200 µg £59
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Frieler RA, et al. 2017. Exp Neurol. 298:104. PubMed
  2. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  3. Hepler C et al. 2017. eLife. 6 pii: e27669. PubMed
  4. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  5. Khorooshi R, et al. 2020. Acta Neuropathol Commun. 8:02. PubMed
  6. Kimura S, et al. 2020. Nat Commun. 0.620833333. PubMed
  7. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  8. Kretschmer I, et al. 2016. J Biol Chem. 291: 4091 - 4106. PubMed
  9. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  10. Liu K, et al. 2021. Cell Metabolism. 33(3):666-675.e4. PubMed
  11. Vercauteren Drubbel A, et al. 2021. Cell Stem Cell. . PubMed
  12. Hagan N, et al. 2020. Cell Death Dis. 1.086111111. PubMed
  13. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  14. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  15. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  16. Xin G, et al. 2021. Cancer Immunol Res. 9:454. PubMed
  17. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  18. d'Errico P, et al. 2021. Nat Neurosci. Online ahead of print. PubMed
  19. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
  20. Sun D, et al. 2021. Cell Stem Cell. . PubMed
  21. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  22. Weng L, et al. 2016. Sci Rep. 6:38632. PubMed
  23. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  24. Cieslik KA, et al. 2018. J Gerontol A Biol Sci Med Sci. 73:1167. PubMed
  25. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  26. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  27. Chen J, et al. 2021. Sci Adv. 7:. PubMed
  28. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  29. Maimets M, et al. 2016. Stem Cell Reports. 6:150-162. PubMed
  30. Wei H, et al. 2020. Cell Death Dis. 11:290. PubMed
  31. Ogawa M, et al. 2019. J Biol Methods. 5:e102. PubMed
  32. Shmeleva EV, et al. 2019. Front Immunol. 10:1780. PubMed
  33. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  34. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  35. Catrina AM, et al. 2021. Rom J Morphol Embryol. 62:109. PubMed
  36. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  37. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  38. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  39. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  40. Rafiq S, et al. 2018. Nat Biotechnol. 36:847. PubMed
  41. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  42. Wang Y, et al. 2021. Nat Commun. 12:2343. PubMed
  43. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  44. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  45. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  46. Galle E, et al. 2022. Genome Biol. 23:207. PubMed
  47. Aoki H, et al. 2009. Development. 136:2511. PubMed
  48. Guha S, et al. 2014. Brain Behav Immun. 11:123. PubMed
  49. An YA et al. 2017. eLife. 6 pii: e24071. PubMed
  50. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  51. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  52. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  53. Serrano Martinez P, et al. 2022. iScience. 25:105047. PubMed
  54. Ogawa-Wong A, et al. 2022. Metabolites. 12:. PubMed
  55. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  56. Endo Y, et al. 2020. FASEB J. 34:16086. PubMed
  57. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  58. Green DP, et al. 2019. Neuron. 101:412. PubMed
  59. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  60. An J, et al. 2022. iScience. 25:103570. PubMed
  61. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  62. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  63. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  64. Fontana D, et al. 2020. Hemasphere. e497:4. PubMed
  65. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  66. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  67. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  68. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  69. Sardella C, et al. 2018. J Invest Dermatol. 138:500. PubMed
  70. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  71. Oliver J, et al. 2009. J Am Soc Nephrol. 2.440972222. PubMed
  72. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  73. Chang CS, et al. 2022. iScience. 25:103738. PubMed
  74. Sinha VC, et al. 2021. Nat Commun. 12:5024. PubMed
  75. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  76. Hu J, et al. 2022. J Neuroinflammation. 19:71. PubMed
  77. Slezak AJ, et al. 2022. ACS Cent Sci. 8:1435. PubMed
  78. Yu Y, et al. 2022. Nat Commun. 13:6857. PubMed
  79. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  80. Yang Z, et al. 2020. Sci Rep. 17757:10. PubMed
  81. Socodato R, et al. 2020. Sci Signal. 13: . PubMed
  82. Khatib–Massalha E, et al. 2020. Nat Commun. 2.921527778. PubMed
  83. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  84. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  85. Bauer T, et al. 2021. Life (Basel). 11:. PubMed
  86. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  87. Ebrahimi-Nik H, et al. 2021. Nat Commun. 12:6423. PubMed
  88. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  89. Wilson DH, et al. 2020. Nat Commun. 0.767361111. PubMed
  90. Ito T, et al. 2021. Commun Biol. 4:694. PubMed
  91. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  92. Barker KA, et al. 2021. Journal of Clinical Investigation. 131(11):. PubMed
  93. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  94. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  95. Wang QA et al. 2018. Cell metabolism. 28(2):282-288 . PubMed
  96. Khare P, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.09.002. PubMed
  97. Feng J,et al. 2017. Nat Commun. . 10.1038/s41467-017-01056-8. PubMed
  98. Douam F, et al. 2017. Mbio. 10.1128/mBio.00819-17. PubMed
  99. Sun H, et al. 2022. Front Immunol. 13:818017. PubMed
  100. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
  101. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  102. Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed
  103. Meng X, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  104. Hu M, et al. 2020. Cancer Immunol Res. 8:1150. PubMed
  105. Kitajima Y, et al. 2022. Cells. 11:. PubMed
  106. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  107. Wijewarnasuriya D, et al. 2020. Cancer Immunol Res. 0.841666667. PubMed
  108. Bota-Rabassedas N, et al. 2021. Cell Reports. 35(3):109009. PubMed
  109. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  110. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  111. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  112. McCallion A, et al. 2022. Front Immunol. 13:961599. PubMed
  113. Matsumoto A, et al. 2021. iScience. 24:102839. PubMed
  114. Lee-Chang C, et al. 2021. J Exp Med. 218:. PubMed
  115. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  116. Senthil K, et al. 2021. Invest Ophthalmol Vis Sci. 62:38. PubMed
  117. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  118. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  119. Dholakia J, et al. 2022. Gynecol Oncol. 164:170. PubMed
  120. Wang Y, et al. 2022. Front Immunol. 13:847581. PubMed
  121. Kronborg Hansen AK, et al. 2022. Int J Mol Sci. 23:. PubMed
  122. Bao Z, et al. 2020. Ann Transplant. 25:e921287. PubMed
  123. Montel‐Hagen A et al. 2019. Cell stem cell. 24(3):376-389 . PubMed
  124. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  125. Liu X, et al. 2021. Int J Med Sci. 18:3125. PubMed
  126. Song E, et al. 2020. Nature. 577:689. PubMed
  127. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  128. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
  129. Milon B, et al. 2021. Cell Rep. 36:109758. PubMed
  130. Dieu RS, et al. 2021. Front Neurosci. 15:685645. PubMed
  131. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  132. Liao Y, et al. 2020. Theranostics. 7.113888889. PubMed
  133. Watson N, et al. 2015. J Immunol. 194:2796. PubMed
  134. Liu B, et al. 2013. Development. 140:780. PubMed
  135. Xu L, et al. 2019. Haematologica. 10.3324/haematol.2018.207258. PubMed
  136. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  137. Wang X, et al. 2021. Inflammation. 44:1815. PubMed
  138. Sanz-Ros J, et al. 2022. Sci Adv. 8:eabq2226. PubMed
  139. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  140. Korin B, et al. 2020. Sleep. :43. PubMed
  141. An X, et al. 2020. Thyroid. . PubMed
  142. Bollinger JL, et al. 2020. Neuropsychopharmacology. 45:1766. PubMed
  143. Yue F, et al. 2022. Cell Rep. 38:110267. PubMed
  144. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  145. Nakao M, et al. 2021. Sci Rep. 11:18384. PubMed
  146. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  147. Wen G, et al. 2018. J Am Heart Assoc. 7:e008187. PubMed
  148. Stone S et al. 2018. Glia. 66(7):1331-1345 . PubMed
  149. Orhon I, et al. 2021. Autophagy. :1. PubMed
  150. Szõke D, et al. 2021. Nat Commun. 12:3460. PubMed
  151. Lau A, et al. 2022. Sci Adv. 8:eabm0142. PubMed
  152. Hung G, et al. 2022. NPJ Aging. 8:10. PubMed
  153. Gawish R, et al. 2022. Elife. 11:. PubMed
  154. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  155. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  156. Singh K, et al. 2021. Front Immunol. 640837:12. PubMed
  157. Engelmann R, et al. 2017. J Negat Results Biomed. 16:05. PubMed
  158. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  159. Lehmann ML, et al. 2018. Sci Rep. 8:11240. PubMed
  160. Lehmann M, et al. 2020. Cell Signal. 70:109588. PubMed
  161. Cugurra A, et al. 2021. Science. 373:. PubMed
  162. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  163. Lupan AM, et al. 2021. Aging (Albany NY). 13:15875. PubMed
  164. Li J, et al. 2021. eLife. 10:00. PubMed
  165. Simula L, et al. 2020. Cell Death Differ. 27:2749. PubMed
RRID
AB_312970 (BioLegend Cat. No. 103105)
AB_312971 (BioLegend Cat. No. 103106)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account